Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)

Summary

This research study is designed to selectively deplete CD117-positive cells from participants with AML and MDS-EB.

Timeline

Start

2022-02-14

Primary completion

2023-02-02

Completion

2023-02-02

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications